Compare Davita Inc (DVA) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Davita Inc vs Nuwellis Inc — how do they compare? Davita Inc trades at $232 (market cap $15.12B), while Nuwellis Inc trades at $3.16 (market cap $1.02M). The key difference: Davita Inc is far larger — about 14823.5× Nuwellis Inc's market cap, and Davita Inc is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| DVA | NUWE | |
|---|---|---|
Market Cap | $15.12B | $1.02M |
Sector | Health | Technology |
52-Week High | $235.71 | $558.26 |
52-Week Low | $103.87 | $2.80 |
Enterprise Value | $27.67B | -$789.97K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Davita Inc
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,100 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives approximately 69% of U.S. sales at government (primarily Medicare) reimbursement rates, with the remaining 31% coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Read more on DVA →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
